Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12+
SponsorCentre Hospitalier Universitaire de Saint Etienne

About this trial

Wilson's disease is a genetic disorder, resulting from an anomaly present on the ATP7B gene located on chromosome 13, causing a progressive accumulation of copper in various organs such as the liver, nervous system and cornea, leading to various hepatic and neurological disorders and a systemic evolution.

Currently, the first-line treatment for this disease is D-Penicillamine, which acts by chelation and promotes copper excretion through the urine. Unfortunately, this treatment also has significant side-effects, particularly on the skin. However, the pathogenesis of elastopathy in patients with Wilson's disease has yet to be fully characterized, and needs to be better understood in order to adapt the therapeutic strategy.

A silicon mold will be made on Wilson's disease patients, enabling the skin micro-relief to be shaped, and analyzed by confocal laser in comparison with the skin of healthy volunteers.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patient over 12 years old

Patient with Wilson's disease confirmed by genetic analysis

Patient followed up in the Wilson's Disease Reference Center for his care

Patient treated with D-Penicillamine

Disqualifiers

Patient not taking a treatment (at investigator's discretion) that may modify skin elasticity

Patient with pathological lesion(s) on forearm or cheek

Patient with a potentially active/rejuvenative forearm or cheek treatment

Patient having applied cream and/or make-up to the areas to be molded (forearm and cheek)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Preparation of forearm molds with SILFLO® silicone

    Other intervention

    Preparation of forearm molds with SILFLO® silicone (MONADERM, Monaco), CE-marked and already used routinely in dermocosmetics. These molds will, then, be analyzed.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: D-penicillamineExperimental treatment 1 intervention
Group B: Healthy patientsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Skin tension measurement

Measurement of skin tension indices on a silicone cast of the inner forearm with a confocal laser expressed as a percentage (from 0 (perfect tension balance) to 100 (absolute imbalance on one tension axis)) of patients treated with D-Penicillamine and healthy patients.

Time frame
At inclusion

Secondary outcomes

1

Skin tension indices measurement on silicone casts

Measurement of skin tension indices on silicone casts of the inner and outer forearm with confocal laser and comparison between different groups of patients according to duration of exposure to treatment in subgroups: (\< to 5 years, 5 to 10 years, 10 to 15 years and 15 years and more).

Time frame
Year 1
2

Skin tension indice measurement with confocal laser

Measurement of skin tension indices on various silicone casts of the inner and outer forearm and cheek with confocal laser and comparison between patients and age- and sex-matched control group patients

Time frame
Year 1

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.